Format

Send to

Choose Destination
Infect Dis Clin North Am. 2000 Jun;14(2):409-33, ix.

Ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations.

Author information

1
Division of Infectious Diseases, John F. Kennedy Memorial Medical Center, West Palm Beach, Florida, USA.

Abstract

Although research and development of new penicillins have declined, penicillins continue to be essential antibiotics for the treatment and prophylaxis of infectious diseases. The most recent additions are the ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations. This article reviews the spectrum of activity, toxicity, pharmacokinetics, and clinical uses of the ureidopenicillins, and the beta-lactam/beta-lactamase inhibitor combination agents.

PMID:
10829263
DOI:
10.1016/s0891-5520(05)70255-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center